Sabour S, Harrington K, Martinson E, Bhatnagar A, Huang J, Duffy D
J Clin Microbiol. 2024; 62(12):e0122024.
PMID: 39565121
PMC: 11633150.
DOI: 10.1128/jcm.01220-24.
Vega A, DeRonde K, Jimenez A, Piazza M, Vu C, Martinez O
Antimicrob Agents Chemother. 2024; 68(5):e0147423.
PMID: 38602418
PMC: 11064525.
DOI: 10.1128/aac.01474-23.
Ruedas-Lopez A, Alonso-Garcia I, Lasarte-Monterrubio C, Guijarro-Sanchez P, Gato E, Vazquez-Ucha J
Antimicrob Agents Chemother. 2021; 66(2):e0206721.
PMID: 34930034
PMC: 8846482.
DOI: 10.1128/AAC.02067-21.
Rao J, Adenikinju A, Kerkering T, Garner D, Jensen R
Microbiol Resour Announc. 2021; 10(35):e0077421.
PMID: 34472982
PMC: 8411920.
DOI: 10.1128/MRA.00774-21.
Bahr G, Gonzalez L, Vila A
Chem Rev. 2021; 121(13):7957-8094.
PMID: 34129337
PMC: 9062786.
DOI: 10.1021/acs.chemrev.1c00138.
Mobile Carbapenemase Genes in .
Yoon E, Jeong S
Front Microbiol. 2021; 12:614058.
PMID: 33679638
PMC: 7930500.
DOI: 10.3389/fmicb.2021.614058.
The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria.
Hammoudi Halat D, Ayoub Moubareck C
Antibiotics (Basel). 2020; 9(4).
PMID: 32316342
PMC: 7235769.
DOI: 10.3390/antibiotics9040186.
Co-existence of VIM-2-producing and KPC-2 and OXA-232-co-producing in the United States.
Palavecino E, Ramirez K, Greene S, Kilic A
Ann Lab Med. 2019; 40(3):267-269.
PMID: 31858769
PMC: 6933063.
DOI: 10.3343/alm.2020.40.3.267.
Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.
Spalding Walters M, Grass J, Bulens S, Hancock E, Phipps E, Muleta D
Emerg Infect Dis. 2019; 25(7):1281-1288.
PMID: 31211681
PMC: 6590762.
DOI: 10.3201/eid2507.181200.
Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.
Karampatakis T, Antachopoulos C, Tsakris A, Roilides E
Eur J Clin Microbiol Infect Dis. 2018; 37(7):1211-1220.
PMID: 29644540
DOI: 10.1007/s10096-018-3244-4.
Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.
El Chakhtoura N, Saade E, Iovleva A, Yasmin M, Wilson B, Perez F
Expert Rev Anti Infect Ther. 2018; 16(2):89-110.
PMID: 29310479
PMC: 6093184.
DOI: 10.1080/14787210.2018.1425139.
First Report of a Verona Integron-Encoded Metallo-β-Lactamase-Producing Klebsiella pneumoniae Infection in a Child in the United States.
Tamma P, Suwantarat N, Rudin S, Logan L, Simner P, Rojas L
J Pediatric Infect Dis Soc. 2016; 5(3):e24-7.
PMID: 27147714
PMC: 5125454.
DOI: 10.1093/jpids/piw025.
Comparison of Verona Integron-Borne Metallo-β-Lactamase (VIM) Variants Reveals Differences in Stability and Inhibition Profiles.
Makena A, Duzgun A, Brem J, McDonough M, Rydzik A, Abboud M
Antimicrob Agents Chemother. 2015; 60(3):1377-84.
PMID: 26666919
PMC: 4775916.
DOI: 10.1128/AAC.01768-15.
Biochemical Characterization of VIM-39, a VIM-1-Like Metallo-β-Lactamase Variant from a Multidrug-Resistant Klebsiella pneumoniae Isolate from Greece.
Papagiannitsis C, Pollini S, De Luca F, Rossolini G, Docquier J, Hrabak J
Antimicrob Agents Chemother. 2015; 59(12):7811-4.
PMID: 26369975
PMC: 4649142.
DOI: 10.1128/AAC.01935-15.
Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.
Hong D, Bae I, Jang I, Jeong S, Kang H, Lee K
Infect Chemother. 2015; 47(2):81-97.
PMID: 26157586
PMC: 4495280.
DOI: 10.3947/ic.2015.47.2.81.
Antibiotic-resistant gram-negative bacterial infections in patients with cancer.
Perez F, Adachi J, Bonomo R
Clin Infect Dis. 2014; 59 Suppl 5:S335-9.
PMID: 25352627
PMC: 4303050.
DOI: 10.1093/cid/ciu612.
Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast Ohio.
Perez F, Hujer A, Marshall S, Ray A, Rather P, Suwantarat N
Antimicrob Agents Chemother. 2014; 58(10):5929-35.
PMID: 25070102
PMC: 4187935.
DOI: 10.1128/AAC.02372-14.
Antibiotic Susceptibility Patterns and Molecular Epidemiology of Metallo-β-Lactamase Producing Pseudomonas Aeruginosa Strains Isolated From Burn Patients.
Japoni A, Anvarinejad M, Farshad S, Giammanco G, Rafaatpour N, Alipour E
Iran Red Crescent Med J. 2014; 16(5):e10916.
PMID: 25031843
PMC: 4082503.
DOI: 10.5812/ircmj.10916.
His224 alters the R2 drug binding site and Phe218 influences the catalytic efficiency of the metallo-β-lactamase VIM-7.
Leiros H, Skagseth S, Edvardsen K, Lorentzen M, Bjerga G, Leiros I
Antimicrob Agents Chemother. 2014; 58(8):4826-36.
PMID: 24913158
PMC: 4136046.
DOI: 10.1128/AAC.02735-13.
The current spectrum of infection in cancer patients with chemotherapy related neutropenia.
Nesher L, Rolston K
Infection. 2013; 42(1):5-13.
PMID: 23975584
DOI: 10.1007/s15010-013-0525-9.